S100A8/A9-dependent reduction in expression of cyclin B1 and hyperphosphorylation of p-Cdc2 (Thr14/Tyr15) shown in this study are consistent with Cdc2 inactivation and G2/M checkpoint arrest as commonly reported in carcinomas [45]–[47]. Here, IGKV1D-22 is linked to carcinoma.